An analytical study of drug utilization, disease progression, and adverse events among 165 COVID-19 patients

BACKGROUND: The coronavirus disease 2019 (COVID-19) epidemic has lasted for nearly 4 months by this study was conducted. We aimed to describe drug utilization, disease progression, and adverse drug events of COVID-19. METHODS: A retrospective, single-center case series study enrolled 165 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Feng, Kou, Hao, Wang, Shengfeng, Lu, Yun, Zhao, Houyu, Li, Wenjing, Zhou, Qingxin, Jiang, Qiaoli, Cheng, Yinchu, Yang, Kun, Zhuo, Lin, Xu, Yang, Wu, Dongfang, Zhan, Siyan, Cheng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944318/
https://www.ncbi.nlm.nih.gov/pubmed/33708933
http://dx.doi.org/10.21037/atm-20-4960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944318/
https://www.ncbi.nlm.nih.gov/pubmed/33708933
http://dx.doi.org/10.21037/atm-20-4960

Ejemplares similares